Blood clots more likely in people with COVID-19 infections than vaccines, study shows
Research from Oxford University in England has new data regarding the rate of blood clotting cases in COVID-19 patients and vaccine recipients. The study, which has not been peer-reviewed yet, shows that the particular blood clot which was studied is eight to ten times more common in people who experience a COVID-19 infection than in people who were inoculated. Dr. David Agus joins "CBS This Morning" to explain the latest development.cbsnews.com
Ovarian cancer -- or is it?
For years, ovarian cancer has remained one of the leading causes of death for women with cancer. Oral contraceptive (birth control) pills, when taken for years, reduce the risk of ovarian cancer by as much as 50%. Many cases of the most common type of ovarian cancer, called high-grade serous carcinoma, are not ovarian at all – they start in the fallopian tube. The genes that are mutated and drive the growth of ovarian cancer cells are also mutated in STIC lesions, suggesting that they may come before actual cancer. Older studies from Europe suggest that taking this action may reduce ovarian cancer rates for a large population.
Breakthroughs in prostate cancer treatment
Breakthroughs in prostate cancer treatment New research into the treatment of prostate cancer could bump survivor rate by 30 percent over the next decade. Dr. David Agus joins the "CBS This Morning" co-hosts to discuss promising aspects of the research.cbsnews.com